Lanean...
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Tuberculosis is the leading infectious disease killer globally due to a single pathogen. Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine (bacille Calmette Guerin, BCG), the global tuberculosis epidemic is inadequately controlled. Novel, effective vaccine(s) are a...
Gorde:
| Argitaratua izan da: | Semin Immunol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Academic Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7786643/ https://ncbi.nlm.nih.gov/pubmed/33279383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2020.101431 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|